Научно-практическая ревматология (Mar 2023)

Clinical significance of antiDFS70 in immunoinflammatory rheumatic diseases (review)

  • T. A. Panafidina,
  • Zh. G. Verizhnikova,
  • A. S. Avdeeva,
  • T. V. Popkova,
  • E. L. Nasonov

DOI
https://doi.org/10.47360/1995-4484-2023-100-105
Journal volume & issue
Vol. 61, no. 1
pp. 100 – 105

Abstract

Read online

The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis. Recent data on the significance of anti-DFS70 have opened up new possibilities for optimizing the step-by-step diagnosis of IIRD. The detection of these antibodies can help in the interpretation of a positive result for antinuclear antibodies (ANA) by indirect immunofluorescence assay on HEp-2 cells (IIFA-HEp-2) in the absence of autoantibodies specific for IIRD. Detection of anti-DFS70 in antinuclear factor (ANF) seropositive patients without clinical and/or serological markers characteristic of a certain disease from the IIRD group can be considered as a potential marker that excludes this group of diseases.

Keywords